These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8769635)

  • 41. [Immune response to basic myelin proteins in herpes simplex virus infections].
    Libíková H; Rajcáni J; Tuková M; Matis J; Pogády J
    Bratisl Lek Listy; 1985 Apr; 83(4):383-94. PubMed ID: 2408716
    [No Abstract]   [Full Text] [Related]  

  • 42. [Herpetic infection of the oral cavity in guinea pigs].
    Antonova NI
    Vopr Virusol; 1977; (1):92-5. PubMed ID: 198963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Herpes simplex virus vaccines.
    Wise TG; Pavan PR; Ennis FA
    J Infect Dis; 1977 Nov; 136(5):706-11. PubMed ID: 199677
    [No Abstract]   [Full Text] [Related]  

  • 45. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: an effective means of inhibiting virus replication in vitro.
    Norley SG; Huang L; Rouse BT
    J Immunol; 1986 Jan; 136(2):681-5. PubMed ID: 3001182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Herpes simplex viruses.
    Whitley RJ; Kimberlin DW; Roizman B
    Clin Infect Dis; 1998 Mar; 26(3):541-53; quiz 554-5. PubMed ID: 9524821
    [No Abstract]   [Full Text] [Related]  

  • 47. Synergistic antiviral effects of adenine arabinoside and humoral antibodies in experimental encephalitis due to Herpesvirus hominis.
    Cho CT; Feng KK; Brahmacupta N
    J Infect Dis; 1976 Feb; 133(2):157-67. PubMed ID: 173763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immune evasion by herpes simplex viruses].
    Retamal-Díaz AR; Suazo PA; Garrido I; Kalergis AM; González PA
    Rev Chilena Infectol; 2015 Feb; 32(1):58-70. PubMed ID: 25860047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral infection of newborn guinea pigs with herpes simplex virus type 1.
    Blaskovic D; Svobodová J; Weidnerová K; Stastný B
    Acta Virol; 1971 Nov; 15(6):522. PubMed ID: 4400435
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunogenic properties of formalin herpes antigen prepared from cell cultures.
    Benda R; Dbalý V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):237-49. PubMed ID: 4354219
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2.
    Walz MA; Price RW; Hayashi K; Katz BJ; Notkins AL
    J Infect Dis; 1977 May; 135(5):744-52. PubMed ID: 192810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus.
    Meignier B; Jourdier TM; Norrild B; Pereira L; Roizman B
    J Infect Dis; 1987 May; 155(5):921-30. PubMed ID: 3031174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restarting Lytic Gene Transcription at the Onset of Herpes Simplex Virus Reactivation.
    Cliffe AR; Wilson AC
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy of herpes simplex virus infections: a prospective view.
    Schwartz J; Elizan TS
    Mt Sinai J Med; 1973; 40(5):641-51. PubMed ID: 4125976
    [No Abstract]   [Full Text] [Related]  

  • 55. "Intermediate" antigens induced by herpes simplex virus in brain tissue of white mice.
    Ado AD; Skorik VA
    J Asthma Res; 1971 Jun; 8(4):813-95. PubMed ID: 4330344
    [No Abstract]   [Full Text] [Related]  

  • 56. An inquiry into the mechanisms of herpes simplex virus latency.
    Roizman B; Sears AE
    Annu Rev Microbiol; 1987; 41():543-71. PubMed ID: 2825588
    [No Abstract]   [Full Text] [Related]  

  • 57. [The photodynamic effect in Herpes simplex: a review].
    Jarrat M; Knox J
    Hautarzt; 1975 Jul; 26(7):345-8. PubMed ID: 175035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Present status and task the in study of pathophysiologic mechanism of latent herpes simplex virus infection and the viral re-activation].
    Minagawa H
    Fukuoka Igaku Zasshi; 1995 Jul; 86(7):299-303. PubMed ID: 7665138
    [No Abstract]   [Full Text] [Related]  

  • 59. Passive immune protection by herpes simplex virus-specific monoclonal antibodies with different plaque development inhibition activity.
    Mannini-Palenzona A; Costanzo F; Cassai E; Campana G
    New Microbiol; 1993 Jul; 16(3):205-13. PubMed ID: 8396193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and serological outcome of genital herpes simplex virus (HSV) type 2 inoculation following oral HSV type 1 infection in guinea-pigs.
    Bernstein DI; Lee FK; Echler G; Nahmias AJ
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2365-72. PubMed ID: 2550572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.